Efficacy and pharmacokinetics of ME1100, a novel optimized formulation of arbekacin for inhalation, compared with amikacin in a murine model of ventilator-associated pneumonia caused by Pseudomonas aeruginosa
暂无分享,去创建一个
K. Yanagihara | N. Kaku | K. Kosai | N. Uno | Y. Morinaga | H. Hasegawa | H. Mukae | T. Miyazaki | K. Izumikawa | K. Takeda | Kazuaki Takeda